ESR1 and neoplasm: The ability of 100 mg/kg AZ’6421 to maintain good antagonistic activity in the absence of complete degradation is consistent with a previous finding where the low dose of fulvestrant that was unable to degrade ERα was still able to inhibit ER activity and block tumour growth46.